Interindividual transcriptional regulation of the human biglycan gene involves three common molecular haplotypes

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 33, Issue 4, 2013, Pages 871-880

  Schmitz, Boris ^a   Salomon, Andrea ^b   Rötrige, Alois ^b   Ritter, Martin ^a   Ringelstein, E Bernd ^a   Fischer, Jens W ^c   Paul, Martin ^d   Brand, Eva ^a   Brand, Stefan Martin ^a  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^b UNIVERSITY OF MÜNSTER   (Germany)

^c UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

^d MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

BGN; cardiovascular disease; genetics; molecular haplotypes; mutation; transcription factor

Indexed keywords

BIGLYCAN; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR SP1;

ARTICLE; CARDIOVASCULAR DISEASE; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DNA STRAND; ELECTROPHORETIC MOBILITY; ERYTHROBLASTOSIS; GENE AMPLIFICATION; GENETIC ANALYSIS; GENETIC REGULATION; HAPLOTYPE; HUMAN; HUMAN CELL; ONCOGENE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN INTERACTION; REPORTER GENE; TRANSCRIPTION REGULATION;

5' UNTRANSLATED REGIONS; AGED; AGED, 80 AND OVER; BIGLYCAN; BINDING SITES; CARDIOVASCULAR DISEASES; CHROMATIN IMMUNOPRECIPITATION; ELECTROPHORETIC MOBILITY SHIFT ASSAY; ENDOTHELIAL CELLS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENE EXPRESSION REGULATION; GENES, REPORTER; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; GERMANY; HAPLOTYPES; HEK293 CELLS; HUMANS; MALE; MIDDLE AGED; PROMOTER REGIONS, GENETIC; PROTO-ONCOGENE PROTEINS; SP1 TRANSCRIPTION FACTOR; TRANS-ACTIVATORS; TRANSCRIPTION FACTOR AP-1; TRANSCRIPTION, GENETIC; TRANSFECTION; TRANSFORMING GROWTH FACTOR BETA1;

EID: 84875372077     PISSN: 10795642     EISSN: 15244636     Source Type: Journal    
DOI: 10.1161/ATVBAHA.112.301073     Document Type: Article

References (38)

1. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 1993;362:801-809.
2. Lusis AJ. Atherosclerosis. Nature. 2000;407:233-241.
3. Kolodgie FD, Burke AP, Farb A, Weber DK, Kutys R, Wight TN, Virmani R. Differential accumulation of proteoglycans and hyaluronan in culprit lesions: insights into plaque erosion. Arterioscler Thromb Vasc Biol. 2002;22:1642-1648.
4. Skalén K, Gustafsson M, Rydberg EK, Hultén LM, Wiklund O, Innerarity TL, Borén J. Subendothelial retention of atherogenic lipoproteins in early atherosclerosis. Nature. 2002;417:750-754.
5. Westermann D, Mersmann J, Melchior A, et al. Biglycan is required for adaptive remodeling after myocardial infarction. Circulation. 2008;117:1269-1276.
6. Schaefer L, Babelova A, Kiss E, Hausser HJ, Baliova M, Krzyzankova M, Marsche G, Young MF, Mihalik D, Götte M, Malle E, Schaefer RM, Gröne HJ. The matrix component biglycan is proinflammatory and signals through Toll-like receptors 4 and 2 in macrophages. J Clin Invest. 2005;115:2223-2233.
7. Fisher LW, Heegaard AM, Vetter U, Vogel W, Just W, Termine JD, Young MF. Human Biglycan Gene. J Biol Chem.1991; 266:14371-14377.
8. Lijnen PJ, Petrov VV, Fagard RH. Induction of cardiac fibrosis by transforming growth factor-beta(1). Mol Genet Metab. 2000;71:418-435.
9. Ungefroren H, Lenschow W, Chen WB, Faendrich F, Kalthoff H. Regulation of biglycan gene expression by transforming growth factorbeta requires MKK6-p38 mitogen-activated protein Kinase signaling downstream of Smad signaling. J Biol Chem. 2003;278:11041-11049.
10. Burch ML, Yang SN, Ballinger ML, Getachew R, Osman N, Little PJ. TGF-beta stimulates biglycan synthesis via p38 and ERK phosphorylation of the linker region of Smad2. Cell Mol Life Sci. 2010;67: 2077-2090.
11. Chen WB, Lenschow W, Tiede K, Fischer JW, Kalthoff H, Ungefroren H. Smad4/DPC4-dependent regulation of biglycan gene expression by transforming growth factor-beta in pancreatic tumor cells. J Biol Chem. 2002;277:36118-36128.
12. Ruoslahti E, Yamaguchi Y. Proteoglycans as modulators of growth factor activities. Cell. 1991;64:867-869.
13. Dodge GR, Diaz A, Sanz-Rodriguez C, Reginato AM, Jimenez SA. Effects of interferon-gamma and tumor necrosis factor alpha on the expression of the genes encoding aggrecan, biglycan, and decorin core proteins in cultured human chondrocytes. Arthritis Rheum. 1998;41:274-283.
14. Iozzo RV. Functional network of interactive proteins. J Biol Chem. 1999; 274:18843-18846.
15. Krusius T, Ruoslahti E. Primary structure of an extracellular matrix proteoglycan core protein deduced from cloned cDNA. Proc Natl Acad Sci USA. 1986;83:7683-7687.
16. Krishnan P, Hocking AM, Scholtz JM, Pace CN, Holik KK, McQuillan DJ. Distinct secondary structures of the leucine-rich repeat proteoglycans decorin and biglycan. Glycosylation-dependent conformational stability. J Biol Chem. 1999;274:10945-10950.
17. Tiede K, Melchior-Becker A, Fischer JW. Transcriptional and posttranscriptional regulators of biglycan in cardiac fibroblasts. Basic Res Cardiol. 2010;105:99-108.
18. Buratowski S. Gene expression-where to start. Science. 2008; 322:1804-1805.
19. Carninci P, Sandelin A, Lenhard B, et al. Genome-wide analysis of mammalian promoter architecture and evolution. Nat Genet. 2006;38:626-635.
20. Ungefroren H, Krull NB. Transcriptional regulation of the human biglycan gene. J Biol Chem. 1996;271:15787-15795.
21. Kruglyak L, Nickerson DA. Variation is the spice of life. Nat Genet. 2001;27:234-236.
22. Smale ST, Kadonaga JT. The RNA polymerase II core promoter. Annu Rev Biochem. 2003;72:449-479.
23. Chiang CM, Roeder RG. Cloning of an intrinsic human TFIID subunit that interacts with multiple transcriptional activators. Science. 1995;267:531-536.
24. Hoey T, Weinzierl RO, Gill G, Chen JL, Dynlacht BD, Tjian R. Isolation and characterization of the Drosophila gene encoding the TATA box binding protein, TFIID. Cell. 1993; 72:247-260.
25. Albright SR, Tjian R. TAFs revisited: more data reveal new twists and confirm old ideas. Gene. 2000;242:1-13.
26. Ungefroren H, Groth S, Ruhnke M, Kalthoff H, Fändrich F. Transforming growth factor-beta (TGF-beta) type I receptor/ALK5-dependent activation of the GADD45beta gene mediates the induction of biglycan expression by TGF-beta. J Biol Chem. 2005;280:2644-2652.
27. Pardali K, Kurisaki A, Morén A, ten Dijke P, Kardassis D, Moustakas A. Role of Smad proteins and transcription factor Sp1 in p21(Waf1/ Cip1) regulation by transforming growth factor-beta. J Biol Chem. 2000;275:29244-29256.
28. Bouwman P, Philipsen S. Regulation of the activity of Sp1-related transcription factors. Mol Cell Endocrinol. 2002;195:27-38.
29. Spengler ML, Guo LW, Brattain MG. Phosphorylation mediates Sp1 coupled activities of proteolytic processing, desumoylation and degradation. Cell Cycle. 2008;7:623-630.
30. Shaulian E, Karin M. AP-1 as a regulator of cell life and death. Nat Cell Biol. 2002;4:E131-E136.
31. Heegaard AM, Xie Z, Young MF, Nielsen KL. Transforming growth factor beta stimulation of biglycan gene expression is potentially mediated by sp1 binding factors. J Cell Biochem. 2004;93:463-475.
32. Heegaard AM, Gehron Robey P, Vogel W, Just W, Widom RL, Schøller J, Fisher LW, Young MF. Functional characterization of the human biglycan 5'-flanking DNA and binding of the transcription factor c-Krox. J Bone Miner Res. 1997;12:2050-2060.
33. Wight TN. The ADAMTS proteases, extracellular matrix, and vascular disease: waking the sleeping giant(s)! Arterioscler Thromb Vasc Biol. 2005;25:12-14.
34. Zhen EY, Brittain IJ, Laska DA, Mitchell PG, Sumer EU, Karsdal MA, Duffin KL. Characterization of metalloprotease cleavage products of human articular cartilage. Arthritis Rheum. 2008;58:2420-2431.
35. Melching LI, Fisher WD, Lee ER, Mort JS, Roughley PJ. The cleavage of biglycan by aggrecanases. Osteoarthr Cartil. 2006;14:1147-1154.
36. Didangelos A, Mayr U, Monaco C, Mayr M. Novel role of ADAMTS-5 protein in proteoglycan turnover and lipoprotein retention in atherosclerosis. J Biol Chem. 2012;287:19341-19345.
37. Barrett JC, Clayton DG, Concannon P, et al.; Type 1 Diabetes Genetics Consortium. Genome-wide association study and meta-analysis find that over 40 loci affect risk of type 1 diabetes. Nat Genet. 2009;41:703-707.
38. Middelberg RP, Ferreira MA, Henders AK, Heath AC, Madden PA, Montgomery GW, Martin NG, Whitfield JB. Genetic variants in LPL, OASL and TOMM40/APOE-C1-C2-C4 genes are associated with multiple cardiovascular-related traits. BMC Med Genet. 2011;12:123.